HealthTech

Ro

Ro raises $150M Series D at $7B valuation

$150M
Total Raised
Series D
Latest Round
2017
Founded
600+
Employees
30 West 21st Street, New York, NY 10010
1 min read

Quick Facts

Valuation
$7B
Latest Round Size
$150M
Latest Round Date
March 2024

Ro: Series D Funding Round

Ro has successfully raised $150M in Series D funding, reaching a valuation of $7B.

Company Overview

Direct-to-patient telehealth

Funding Details

The Series D round was led by General Catalyst, with participation from Torch Capital, Initialized Capital, SignalFire, Slow Ventures.

Company Information

  • Headquarters: 30 West 21st Street, New York, NY 10010
  • Founded: 2017
  • Employees: 600+
  • Category: HealthTech

Investment

Ro plans to use the funds to accelerate product development, expand its team, and scale operations globally.

About the Investors

  • General Catalyst: Verified investor in Series D
  • Torch Capital: Verified investor in Series D
  • Initialized Capital: Verified investor in Series D
  • SignalFire: Verified investor in Series D
  • Slow Ventures: Verified investor in Series D

Key Investors

General Catalyst
Lead Investor
Verified investor in Series D
Torch Capital
Investor
Verified investor in Series D
Initialized Capital
Investor
Verified investor in Series D
SignalFire
Investor
Verified investor in Series D
Slow Ventures
Investor
Verified investor in Series D

About the Author

Editorial Team
Editorial Team
Curated funding news from verified sources